Pharma Focus Asia

Indiana University Unveils First-of-its-kind Gene Therapy for Amyotrophic Lateral Sclerosis

Indiana University has unveiled first-of-its-kind Qalsody (tofersen), gene-based therapy for a rare form of amyotrophic lateral sclerosis (ALS) caused by mutations in the superoxide dismutase 1 (SOD1) gene.

This development marks a significant advancement in the treatment of ALS, offering hope to patients with specific genetic mutations associated with the disease.

The method of delivery through spinal injection allows the medication to directly target the central nervous system, potentially maximising its effectiveness. The treatment regimen, consisting of three initial doses followed by monthly doses, aims to slow down the progression of ALS and provide long-term benefits to patients.

Amyotrophic lateral sclerosis (ALS) is a devastating and progressive condition with limited treatment options, the approval of Qalsody represents a promising step forward in the field of neurology. By targeting specific gene variants of the disease, this therapy addresses an unmet need in ALS treatment and offers new hope for patients and their families.

As gene therapies for neuromuscular disorders are relatively new in clinical practise, the introduction of Qalsody underscores the importance of ongoing research and innovation in the field of neurology. 

This development opens up new possibilities for the treatment of ALS and other neurological genetic disorders, potentially transforming the outlook for patients living with these conditions.
 

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024